Study guide

1.2 Clinical Breast Examination & Breast Awareness Education

CBCN Certified Breast Care Nurse Exam

Track your progress as you read

Finished sections get a check mark.

1 Introduction: The CBCN Exam

CBCN Exam Facts, 2026 Blueprint & Study Plan

2 Chapter 1: Breast Health, Examination & Benign Conditions (Care Continuum)

1.1 Breast Anatomy, Vascular Supply & Hormonal Physiology 1.2 Clinical Breast Examination & Breast Awareness Education 1.3 Benign Breast Conditions, Mastalgia & Fibrocystic Changes

3 Chapter 2: Screening, Breast Density & Special Populations (Care Continuum)

2.1 Screening Modalities, Breast Density & Pharmacologic Risk Reduction 2.2 Screening & Breast Health in Special Populations

4 Chapter 3: Cancer Risk Assessment & Genetics (Care Continuum)

3.1 Proliferative Lesions, Atypia & High-Risk Benign Pathology 3.2 Breast Cancer Risk Models (Gail, Tyrer-Cuzick, Claus, BRCAPRO) 3.3 Hereditary Cancer Syndromes & Genetic Evaluation

5 Chapter 4: Patient Navigation, Surveillance & Survivorship (Care Continuum)

4.1 Patient Navigation, Barriers to Care, Social Determinants & Interprofessional Collaboration 4.2 Survivorship Care Planning, Surveillance Intervals & Recurrence Monitoring 4.3 Secondary Prevention, Physical Activity, Nutrition & Wellness Guidance

6 Chapter 5: Carcinogenesis & Diagnostic Evaluation (Diagnosis and Staging)

5.1 Carcinogenesis: How Breast Cancer Develops and Spreads 5.2 Clinical Assessment, Diagnostic Imaging & BI-RADS Categorization 5.3 Breast Biopsy Modalities & Image-Guided Localization Techniques

7 Chapter 6: Pathology, Biomarkers & Genomic Testing (Diagnosis and Staging)

6.1 Histopathology: In Situ Carcinomas & Invasive Carcinoma Subtypes 6.2 Receptor Biomarkers (ER, PR, HER2, Ki-67) & Molecular Subtypes 6.3 Multigene Genomic Assays & Recurrence Risk Stratification

8 Chapter 7: Clinical & Pathologic Staging (Diagnosis and Staging)

7.1 AJCC TNM Staging System (Anatomic vs Prognostic Staging) 7.2 Staging Workup: When to Use MRI, CT, Bone Scan & PET

9 Chapter 8: Breast Surgery, Axillary Staging & Reconstruction (Treatment Modalities)

8.1 Breast-Conserving Surgery, Margin Standards & Mastectomy Techniques 8.2 Axillary Staging: Sentinel Lymph Node Biopsy vs. Axillary Dissection 8.3 Post-Mastectomy Reconstruction & Oncoplastic Surgery

10 Chapter 9: Radiation Therapy & Chemotherapy (Treatment Modalities)

9.1 Radiation Therapy: Whole Breast, Chest Wall, Regional Nodal & Partial Breast Irradiation 9.2 Neoadjuvant vs. Adjuvant Chemotherapy Principles & Standard Regimens

11 Chapter 10: Endocrine, HER2-Targeted & Novel Systemic Therapies (Treatment Modalities)

10.1 Endocrine Therapy: SERMs, Aromatase Inhibitors, Ovarian Suppression & SERDs 10.2 HER2-Targeted Monoclonal Antibodies, Antibody-Drug Conjugates & Kinase Inhibitors 10.3 CDK4/6 Inhibitors, PARP Inhibitors & Immune Checkpoint Blockade 10.4 Trop-2 Antibody-Drug Conjugates, PI3K/AKT/mTOR Inhibitors & New Oral SERDs

12 Chapter 11: Specific Conditions & Special Populations (Treatment Modalities)

11.1 Triple-Negative Breast Cancer: Treatment Considerations 11.2 HER2-Positive Breast Cancer: Treatment Considerations 11.3 Inflammatory Breast Cancer & Paget Disease of the Nipple 11.4 Phyllodes Tumors & Breast Angiosarcoma 11.5 Treatment Considerations for Special Populations

13 Chapter 12: Symptom Management & Supportive Care (Nursing Practice)

12.1 Acute Chemotherapy Toxicities, Supportive Regimens & Oncologic Emergencies 12.2 Lymphedema Pathophysiology, ISL Staging & Complete Decongestive Therapy (CDT) 12.3 Musculoskeletal Toxicities, Bone Health & Vasomotor/GSM Relief 12.4 Complementary & Integrative Modalities 12.5 Cancer Rehabilitation: Physical, Occupational & Pelvic Floor Therapy

14 Chapter 13: Oncologic Emergencies (Nursing Practice)

13.1 Oncologic Emergencies I: Spinal Cord Compression, Hypercalcemia, Tamponade & SVC Syndrome 13.2 Oncologic Emergencies II: Hypersensitivity & Anaphylaxis, Sepsis, Pleural Effusion & Thromboembolism

15 Chapter 14: Professional Practice, Clinical Trials & Self-Care (Nursing Practice)

14.1 Professional Practice: Guidelines, Ethics, Legislation, Outreach & Accreditation 14.2 Clinical Trials in Breast Oncology 14.3 Nurse Self-Care: Compassion Fatigue, Burnout, Moral Distress & Substance Use

16 Chapter 15: Psychosocial Dimensions of Care (Psychosocial Dimensions)

15.1 Psychosocial Distress, Coping, Grief & Palliative Care 15.2 Culture, Spirituality, Sexual & Gender Identity, Age & Healthcare Disparities 15.3 Family & Caregiver Dynamics 15.4 Altered Body Image 15.5 Reproductive & Sexual Health

1.2 Clinical Breast Examination & Breast Awareness Education

Key Takeaways Explain This Topic AI

A complete clinical breast examination includes inspection in several positions, vertical-strip palpation from clavicle to inframammary fold and sternum to midaxillary line, three levels of pressure, and nodal palpation.

Findings are documented by breast side, clock-face position, distance in centimeters from the nipple, size, shape, consistency, mobility, tenderness, and any skin or nipple change.

The ACS does not recommend routine CBE for average-risk women, while NCCN advises a clinical encounter every 1 to 3 years from age 25 to 39 and annually from 40.

Breast self-awareness means knowing how one's breasts normally look and feel and promptly reporting changes, rather than performing a rigid monthly self-exam ritual.

Last updated: September 2026

Why the CBE Still Matters

Mammography finds most screen-detected cancers, but roughly 10% to 15% of cancers are not visible on mammography, and many cancers in younger women present as a lump the woman or a clinician feels. A skilled clinical breast examination (CBE) is also the backbone of symptom evaluation, survivorship follow-up, and chest wall surveillance after mastectomy. Breast care nurses perform CBEs, teach patients what is normal for them, and triage what needs imaging.

Performing the Examination

A thorough, structured Clinical Breast Examination (CBE) remains a foundational physical assessment tool in breast care nursing and clinical oncology.

Systematic Physical Assessment Technique

Inspection in Four Positions :

Arms relaxed at sides : Evaluates baseline breast symmetry, skin contours, color, and nipple position.

Arms raised directly overhead : Stretches pectoral attachments and suspensory ligaments, accentuating subtle skin dimpling, tethering, or asymmetry in the lower quadrants.

Hands firmly pressed against iliac crests (hips) : Contracts the pectoralis major muscles, revealing pathological fixation of deep-seated masses to the pectoral fascia.

Leaning forward (torso flexed at waist) : Allows large or pendulous breasts to fall forward away from the chest wall, exposing retromammary fixation or subtle inframammary fold tethering.

Palpation Pattern and Pressure Dynamics :

Vertical Strip Pattern : Clinical trials have established that the vertical strip (lawnmower) pattern achieves superior anatomical coverage and lower false-negative rates compared to concentric circular or radial wedge techniques. Palpation proceeds in overlapping vertical swaths from the clavicle down to the inframammary fold, spanning from the sternal margin to the midaxillary line.

Finger Technique & Three-Level Pressure : The examiner utilizes the finger pads of the three middle fingers, applying small, dime-sized circular motions at three distinct depths of pressure:

Light pressure : Assesses the immediate subcutaneous tissue and superficial layer of superficial fascia.

Medium pressure : Evaluates the mid-parenchymal glandular tissue and interlobular stroma.

Deep pressure : Compresses the deep parenchyma and retromammary space against the rigid thoracic ribs.

Evaluation of Nodal Basins and the Nipple-Areolar Complex :

The patient sits upright with the examiner supporting the patient's arm to relax the shoulder girdle muscles while systematically palpating the axillary apex (Level III), central axilla (Level II), anterior/pectoral fold (Level I), and posterior latissimus fold (Level I).

Palpation must include the bilateral supraclavicular and infraclavicular fossae.

The nipple is gently inspected and compressed only if spontaneous discharge is reported, assessing whether the discharge originates from a single duct orifice or multiple ducts.

Clinical Distinction: Benign Nodularity vs. Malignant Lesions

Benign Physiological Nodularity : Typically presents as bilateral, diffuse, symmetrical, granular, or rubbery "cobblestone" tissue, most prominent in the upper outer quadrants. These areas often fluctuate in tenderness and size with the menstrual cycle and remain freely mobile without skin tethering.

Suspicious Malignant Lesions : Typically present as a solitary, unilateral, firm to stony-hard, poorly circumscribed mass with irregular margins. The lesion is often non-tender, fixed to the overlying dermis (causing dimpling) or fixed to the underlying pectoral fascia (immobile upon muscle contraction), and may be accompanied by unilateral spontaneous serosanguinous nipple discharge or palpable, firm, non-tender axillary adenopathy.

Documenting Findings

A useful CBE note lets the next examiner find the same spot. Record:

  • Element Example
  • Side and location Right breast, 10 o'clock
  • Distance from nipple 4 cm from the nipple
  • Size 1.5 × 1.0 cm
  • Shape and margins Oval, smooth, well defined
  • Consistency Rubbery (or soft, firm, hard)
  • Mobility Freely mobile; not fixed to skin or pectoral fascia
  • Tenderness Nontender
  • Skin and nipple No dimpling, erythema, retraction, or discharge
  • Nodes No palpable axillary, supraclavicular, or infraclavicular nodes

Many clinicians add a simple diagram. The clock-face convention is described as if facing the patient, so 10 o'clock on the right breast is upper outer and 10 o'clock on the left breast is upper inner.

Normal Findings That Worry Patients

Inframammary ridge: a firm, crescent-shaped band of tissue along the lower breast, especially in larger breasts.

Physiologic nodularity: diffuse, symmetric, "cobblestone" texture that changes with the menstrual cycle.

Asymmetry: mild size difference between breasts is common and long-standing.

Accessory tissue: axillary breast tissue or supernumerary nipples along the milk line.

Findings That Need Diagnostic Workup

A new dominant mass that is distinct from surrounding tissue, persists through a menstrual cycle, or is hard, irregular, or fixed.

Skin dimpling, retraction, peau d'orange, erythema, or ulceration.

New nipple inversion or deviation, scaling or crusting of the nipple, or spontaneous single-duct serous or bloody discharge.

Palpable axillary, supraclavicular, or infraclavicular nodes.

For a palpable mass, ultrasound is the first test under age 30 (and in pregnancy or lactation); from age 30, diagnostic mammography plus targeted ultrasound is standard. A negative image never overrides a suspicious exam; persistent clinical concern warrants biopsy.

Special Examination Situations

After mastectomy or reconstruction: examine the entire chest wall, the scar, the skin flaps, and the axilla. Recurrences are usually superficial nodules in the skin or along the scar. Implant and flap reconstructions are palpated gently for new nodules.

After lumpectomy and radiation: expect a firm scar and some induration; new change compared with the post-treatment baseline is what matters.

Men: examine the subareolar area and the axilla. Gynecomastia is usually central, symmetric, rubbery, and sometimes tender; cancer is usually eccentric, firm, and painless, with possible nipple retraction.

What the Guidelines Say About CBE

  • Organization Average-risk CBE position
  • American Cancer Society Does not recommend routine CBE for screening

NCCN Clinical encounter with risk assessment and breast awareness education every 1 to 3 years from 25 to 39, then annually from 40

  • ACOG CBE may be offered every 1 to 3 years from 25 to 39 and annually from 40 after shared decision-making
  • USPSTF Evidence insufficient to assess CBE benefits and harms

High-risk patients (for example, BRCA carriers) have CBE every 6 to 12 months as part of their surveillance plan.

Teaching Breast Self-Awareness

Randomized trials of formal monthly breast self-examination did not reduce mortality and increased benign biopsies, so most organizations now promote breast self-awareness :

Know the usual look and feel of your breasts, including cyclical changes.

Report any change promptly: a lump, thickening, skin or nipple change, discharge, or persistent focal pain.

Know your risk and screening schedule.

Do not wait for your next mammogram if you notice a change.

Teach with plain language, models, and teach-back. Patients who prefer a structured monthly self-exam can do one; examining about a week after menses starts avoids premenstrual nodularity. Emphasize that most changes are benign but all deserve evaluation.